Research and analysis

Genetically Modified Organisms: Sanofi Pasteur, Inc. (24/R56/01)

Details of the consent for Sanofi Pasteur, Inc. to release a genetically modified organism, reference 24/R56/01.

• From: Department for Environment, Food & Rural Affairs
• Published: 11 January 2024
• Last updated: 10 May 2024 — See all updates

Documents

Consent letter (reference 24/R56/01)

PDF, 57.1 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Parts A1 to A6: Application for consent to release a GMO – organisms other than higher plants

PDF, 834 KB, 53 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Part B: Information about the release application to be included on the public register

PDF, 253 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Consent documents for Sanofi Pasteur, Inc. to release a genetically modified organism, reference 24/R56/01.

Each consent granted includes:

• consent letter (confirming consent and outlining any conditions)
• part A1-A6: Information required under schedule 1 of the Genetically Modified Organisms (Deliberate Release) regulations 2002
• part B: Information about the release application to be included on the public register

ACRE advice

ACRE advice: application for a vaccine trial of genetically modified Respiratory Syncytial Virus (24/R56/01)

Published 11 January 2024
Last updated 10 May 2024 + show all updates

1. 10 May 2024

   We have updated this application as consent has been granted. We have also added a link to the ACRE advice about the application.

2. 11 January 2024

   First published.